Avalo Therapeutics AVTX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Avalo Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's operating margin?
- Avalo Therapeutics (AVTX) reported operating margin of -15,536.1% in Q4 2024.
- How has Avalo Therapeutics's operating margin changed year-over-year?
- Avalo Therapeutics's operating margin decreased by 993.5% year-over-year, from -1,420.8% to -15,536.1%.
- What is the long-term trend for Avalo Therapeutics's operating margin?
- Over 4 years (2020 to 2024), Avalo Therapeutics's operating margin has grown at a 94.4% compound annual growth rate (CAGR), from -1,087.2% to -15,536.1%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.